Diamonds and Dogs

10/16/19

Johnson and Johnson (JNJ) gets an upgrade on earnings. JNJ rose 1.75% following better than expected earnings, improved 2020 guidance and four upgrades. But the analysts also caution that pending litigation for opioids and their baby powder could keep gains limited.

Workday (WDAY) not working. The stock is down 11% not far from a 9-month low following a number of downgrades. The downgrades come after a user conference when the company indicated delays in signing new contracts and a slowdown in certain sectors. At least four analysts have made cautious comments. The stock is down 29% since the summer highs.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.